Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brendan Flannery

Showing results (31-40 of 232) with videos related to

Pageof 24
Sort By:
Annals of Internal Medicine|November 27, 2023
Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to AcceptanceMark W Tenforde, Fatimah S Dawood, Sascha R Ellington, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2026
Comparison of influenza hemagglutination inhibition titers from capillary blood versus venipunctureAnne-Marie Rick, Rachel Costa, John F Alcorn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United StatesMichelle M Hughes, Carrie Reed, Brendan Flannery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2017
Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15Jill M Ferdinands, Alicia M Fry, Sue Reynolds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2025
Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product RecommendationsEdward A Belongia, Huong Q Nguyen, David L McClure, et al.
Vaccine|March 9, 2020
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018Edward A Belongia, Min Z Levine, Oluwatosin Olaiya, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|December 14, 2011
Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaignAntonia Maria da Silva Teixeira, Samia Abdul Samad, Marcos Aurélio de Souza, et al.
American Journal of Epidemiology|February 2, 2026
Magnitude of potential biases in COVID-19 vaccine effectiveness studies due to differential healthcare seeking following home testing: implications for test negative design studiesSaba A Qasmieh, Jill M Ferdinands, Jessie R Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Magnitude of Potential Biases in COVID-19 Vaccine Effectiveness Studies due to Differential Healthcare seeking following Home Testing: Implications for Test Negative Design StudiesSaba A Qasmieh, Jill M Ferdinands, Jessie R Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory IllnessBrendan Flannery, Jennifer K Meece, John V Williams, et al.
Pageof 24

Showing results (31-40 of 232) with videos related to

Sort By:
Pageof 24
Annals of Internal Medicine|November 27, 2023
Communicating the Value of Influenza Vaccines to Patients: Translating Vaccine Effectiveness to AcceptanceMark W Tenforde, Fatimah S Dawood, Sascha R Ellington, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|May 19, 2026
Comparison of influenza hemagglutination inhibition titers from capillary blood versus venipunctureAnne-Marie Rick, Rachel Costa, John F Alcorn, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 26, 2019
Projected Population Benefit of Increased Effectiveness and Coverage of Influenza Vaccination on Influenza Burden in the United StatesMichelle M Hughes, Carrie Reed, Brendan Flannery, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 1, 2017
Intraseason waning of influenza vaccine protection: Evidence from the US Influenza Vaccine Effectiveness Network, 2011-12 through 2014-15Jill M Ferdinands, Alicia M Fry, Sue Reynolds, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 8, 2025
Approaches to Comparing Influenza Vaccine Effectiveness to Guide Potential Preferential Product RecommendationsEdward A Belongia, Huong Q Nguyen, David L McClure, et al.
Vaccine|March 9, 2020
Clinical trial to assess immunogenicity of high-dose, adjuvanted, and recombinant influenza vaccines against cell-grown A(H3N2) viruses in adults 65 to 74 years, 2017-2018Edward A Belongia, Min Z Levine, Oluwatosin Olaiya, et al.
Revista Panamericana De Salud Publica = Pan American Journal of Public Health|December 14, 2011
Brazilian experience with rapid monitoring of vaccination coverage during a national rubella elimination campaignAntonia Maria da Silva Teixeira, Samia Abdul Samad, Marcos Aurélio de Souza, et al.
American Journal of Epidemiology|February 2, 2026
Magnitude of potential biases in COVID-19 vaccine effectiveness studies due to differential healthcare seeking following home testing: implications for test negative design studiesSaba A Qasmieh, Jill M Ferdinands, Jessie R Chung, et al.
Medrxiv : the Preprint Server for Health Sciences|January 13, 2025
Magnitude of Potential Biases in COVID-19 Vaccine Effectiveness Studies due to Differential Healthcare seeking following Home Testing: Implications for Test Negative Design StudiesSaba A Qasmieh, Jill M Ferdinands, Jessie R Chung, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 21, 2020
Systematic Testing for Influenza and Coronavirus Disease 2019 Among Patients With Respiratory IllnessBrendan Flannery, Jennifer K Meece, John V Williams, et al.
Pageof 24